Totient

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLS) to identify novel tissue-specific antigens and develop corresponding high-affinity antibody therapies. It utilizes machine learning and immune informatics to extract critical insights from large, complex datasets in order to rapidly and accurately assemble the most effective antibody candidates. The unique adaptability of the Totient platform enables the company to maintain flexibility and develop therapies targeting cancer, autoimmune diseases, infections, and viruses.